A coronavirus ‘czar?’ Trump took the opposite course: a 12-member committee
WASHINGTON — President Obama had an Ebola “czar.’’ George W. Bush and Clinton had AIDS…
Category: Politics
STAT Plus: With new rules, FDA aims to spark competition, lower prices for expensive gene therapies
WASHINGTON — The Food and Drug Administration released a slew of gene therapy policies Tuesday…
Top Harvard chemist charged with lying about ties to Chinese government program
The head of Harvard University’s chemistry department was charged on Tuesday with attempting to conceal…
.jpg)
Federal officials tell China: Let U.S. health workers enter to help respond to coronavirus
WASHINGTON — Federal officials on Tuesday called for a team of Americans to be allowed…
It’s the insulin, stupid: How drug pricing’s simplest case study became a top issue for 2020 Democrats
WATERLOO, Iowa — Presidential candidates can’t stop talking about insulin. At a campaign stop here…
Want to know how contentious drug pricing is in Washington? Check the receipts
WASHINGTON — Pfizer, Johnson & Johnson, Merck and the 31 other major drug makers that…
Former Rep. Chris Collins sentenced to 26 months in prison in biotech insider trading scheme
Chris Collins, a former Republican lawmaker and longtime ally of President Trump, was sentenced Friday…
STAT Plus: Airing frustrations with pharma, a Republican FTC commissioner just endorsed Medicare negotiation
WASHINGTON — A Republican member of the Federal Trade Commission on Thursday expressed support for…
FDA and NIH let clinical trial sponsors keep results secret, investigation shows
This story was originally published by Science. It is a follow-up to STAT articles in…
Conservative group with pharma ties makes clear there are drug pricing reforms they can support
WASHINGTON — The conservative American Action Network launched a $4 million advertising campaign Tuesday to…
A spate of new class-action lawsuits threaten the CBD industry. Will they force Washington to act?
WASHINGTON — Since the Food and Drug Administration can’t figure out whether supplements that contain…
3 drug pricing policy experiments to watch in 2020
WASHINGTON — Politicians spent the better part of 2019 bickering over the best way to…
What will 2020 bring for medicine and science? We asked 16 leaders for predictions
Last year, when we asked science and health care soothsayers to peak ahead to 2019,…
3 congressional races to watch in 2020
WASHINGTON — Drug prices are on the ballot once again in 2020. It’s already evident…
2019 was supposed to be the year Washington lowered drug prices. What happened?
WASHINGTON — Lawmakers of all stripes made an agreement the day following the midterm elections…
STAT Plus: One drug maker has a lot more to lose than others, under early drafts of drug importation plans
WASHINGTON — President Trump’s plan to let states and drug wholesalers import medicines from Canada…
Top Republican blasts McConnell for derailing bipartisan drug pricing bill
WASHINGTON — Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.), the bipartisan duo behind the…
STAT Plus: Lawmakers slip a win for pharma into federal spending package
WASHINGTON — Lawmakers quietly tucked a boost for the pharmaceutical industry in the massive, end-of-year…
It’s a bonanza: With drug pricing bill up for a vote, D.C. news outlets are drowning in advocacy ads
WASHINGTON — Pick up this morning’s print edition of Politico and you’ll be hard-pressed to…
Democrats’ drug pricing bill is a sneak peek at the party’s 2020 campaign message
WASHINGTON — If Democrats are spoiling for a 2020 fight focused on anything besides impeaching…
STAT Plus: With new trade deal, Trump deals a blow to drug makers
WASHINGTON — The Trump administration’s Tuesday agreement on a new trade deal with Canada and…
STAT Plus: House Republicans fuel Capitol Hill chaos with competing drug pricing bill
WASHINGTON — Republicans on Monday are set to accelerate Capitol Hill’s drug pricing chaos with…
Revamped, bipartisan Senate package takes aim at drug prices — and props up other health programs, too
WASHINGTON — Leaders of a key Senate committee unveiled a new version of a sweeping,…
STAT Plus: More than 100 small biotech CEOs sound off against Pelosi’s signature drug pricing bill
WASHINGTON — Nearly 150 CEOs of emerging biotech companies are sending a unified, stark message…
STAT Plus: Senators urge Medicare to prevent bias in AI tools used in health care
Two Senate Democrats are challenging Medicare’s top official to investigate how health care tools based…
STAT Plus: Congress is hoping for another major medical research bill. But pharma’s not nearly as excited as before
WASHINGTON — The bipartisan duo behind a 2016 law that poured billions into medical research…
How a billionaire couple greased the skids for Nancy Pelosi’s drug pricing bill
WASHINGTON — When House Democrats pass legislation next month that would slash prescription drug spending…
Stephen Hahn, Trump’s FDA nominee, pledges ‘bold action’ on vaping but sidesteps questions on flavor ban
WASHINGTON — President Trump’s nominee to lead the Food and Drug Administration, faced with a…
STAT Plus: Biotech venture capitalists form a lobbying coalition to join the drug pricing debate
A shorter version of this story first appeared in D.C. Diagnosis, STAT’s weekly newsletter about…